Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Influenza Medication Market Size, Trends, Analysis, Research: By Type: Antiviral Drugs, Antihistamines, Vaccines, Others; By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments; 2022-2027

Global Influenza Medication Market Outlook

The global Influenza medication market size reached a value of USD 1014.5 million by 2021. The market is aided by increasing cases of influenza, and active healthcare systems engaged in combating influenza worldwide. 

 

News and Developments in the Market

In August 2022, Genentech announced that United States’ FDA approved for the use of ‘Xofluza’. It acts as influenza medication for children aged 5 years and older. It is the first-in-class and only single-dose oral medicine that has been approved for children as young as 5 years old. Before the FDA approval was announced, it was used to treat flu in people who have had symptoms for not more than 48 hours and was used only for children aged 12 years and older. 

 

In August 2022, UZ Leuven and KU Leuven carried out a trial with international partners and discovered that patients with influenza or COVID-19 also develop an additional fungal infection ‘aspergillosis' along with various other tissue damage. This study will make way for the development of modified remedies for patients with this double infection, extending the reach of the influenza medication market.

 

In July 2022, Seqirus and a business of CSL Limited (ASX:CSL) partnered for multi-year influenza medication research with the University of Liverpool Pandemic Institute. Seqirus would participate in research projects and inform the generation of the threat of seasonal influenza and develop innovative approaches to the pandemic response. 

 

In April 2022, a new influenza vaccine was developed against a pandemic variant of the H5N1 subunit virus. The vaccine has proved to be highly immunogenic in both younger and the older generations. This virus is mainly found in wild and domestic birds and poultry. Humans are as of now unaffected by this virus, but if it were to affect humans, public health could be severely affected and so the vaccine was developed. 

 

Key Trends in the Market

Influenza is a viral infection that spreads easily and can prove to be fatal at times, due to which there is a strong demand for the influenza medication market. It is usually self-diagnosable and resolves within days or weeks. It spreads through skin-to-skin contact, contact with the saliva of an infected person, by touching a contaminated surface or by airborne respiratory droplets. One can prevent it by taking a vaccine annually. For treatment, rest and fluid intake are considered primary which allows the body to fight the infection on its own. 

 

  • There has been success in understanding the Influenza virus and developing remedies to treat them. However, most significant of all the treatments is vaccination. The Human Vaccines Project started the Universal Influenza Vaccine Initiative in collaboration with various private and government sectors to speed the development of the influenza vaccine.
  • Four authorised antiviral developments ‘Oseltamivir', ‘Zanamivir', ‘Amantadine', and ‘Rimantadine' are likely to rise in the influenza medication market during the forecast period because no other trial could compete with their effectiveness in treatment. Amantadine and Rimantadine reduce the duration of influenza and treat type A infection while Oseltamivir and Zanamivir are neuraminid inhibitors.
  • Increase in the number of affected people by influenza will ultimately steer the demand for influenza drugs all around the globe. Older people who are more prone to this sickness is yet another reason that will surge the demand for influenza medications. This will increase the emphasis on research which will help in better development of treatment protocols, making it a lucrative opportunity for influenza medication market to grow. 

 

Market Analysis

By type, the global Influenza medication market is divided into antiviral drugs, antihistamines, vaccines, and others. On the basis of distribution channels, the market can be divided into hospital pharmacies, retail pharmacies, online, and others. Based on the region, the market is divided into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global influenza medication market, covering their competitive landscape and latest developments.

 

  • Genentech, Inc.
  • Shionogi & Co., Ltd
  • Seqirus Inc.
  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline Plc.
  • Others

 

Market Share by Distribution Channels

Influenza medication products are distributed through various channels, including hospital pharmacies and retail pharmacy stores. With growing technology, they can be easily availed online as well. 

 

Hospital pharmacies hold a dominant share in the market because better care is taken, and treatment is conducted along with medication at the hospital itself through stronger medications which are generally unavailable in the retail market. However, the retail market provides maximum medications in the oral form which are easy to self-administer. Convenient availability of medications online increases its long-term potential as compared to the hospital pharmacy segment. Retail pharmacies, on the other hand, are anticipated to hold the second largest share in the influenza medication market. 

 

Market Distribution by Region

North America has been dominating the influenza medication market and is expected to do the same in the future because of the increase in the medications launched in the region. The Asia Pacific is expected to give a tough competition to North America in the forecast period. Countries, including the United Kingdom, France, and Germany contribute to the growth of the European market.

 

The increasing status of influenza has overall affected the growth of the influenza medication market. That is because there is a rapid growth in influenza, ultimately increasing the mortality rate, thus bolstering the demand for the medication overall and affecting the market. 

 

Competitive Landscape

Seqirus Inc. is the world's largest influenza medication company. Founded in 1916 with headquarters in Australia, the team passionately works with an aim to reduce the impact of influenza globally. Vaccines produced by them help them save millions of people and communities. They have been working with global healthcare partners since 1918. 

 

AstraZeneca PLC is a pharmaceutical company focused on creating the most effective medications innovatively. Based out of Cambridge in the United Kingdom, the company was established in 1999. They not only focus on delivering benefits to the patients but also the health care system and societies globally. They operate in such a way as to form a connection between business growth, the need of society and the limitations of the planet. 

 

Novartis AG is moving ahead with a vision to bring their various treatments such as influenza medications to people in every corner of the world. Established in 1996 with headquarters in Switzerland, they develop breakthrough remedies and always find new ways to deliver to the maximum population possible. 

 

Other market players include Genentech Inc., Shionogi and Co. Ltd., GlaxoSmithKline plc., and others. 

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Distribution Channels
  • Region
Breakup by Type
  • Antiviral Drugs
  • Antihistamines
  • Vaccines
  • Others
Breakup by Distribution Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Genentech, Inc.
  • Shionogi and Co., Ltd.
  • Seqirus Inc.
  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline Plc
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market    
8    Global Influenza Medication Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Influenza Medication Historical Market (2017-2021) 
    8.3    Global Influenza Medication Market Forecast (2022-2027)
    8.4    Global Influenza Medication Market by Type
        8.4.1    Antiviral Drugs
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Antihistamines
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Vaccines
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Influenza Medication Market by Distribution Channels
        8.5.1    Hospital Pharmacies
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Retail Pharmacies
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Online
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Influenza Medication Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021) 
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021) 
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021) 
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021) 
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021) 
            8.6.5.3    Forecast Trend (2022-2027)
9    North America Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2017-2021) 
        9.1.3    Forecast Trend (2022-2027)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2017-2021) 
        9.2.3    Forecast Trend (2022-2027)
10    Europe Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2017-2021) 
        10.1.3    Forecast Trend (2022-2027)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2017-2021) 
        10.2.3    Forecast Trend (2022-2027)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2017-2021) 
        10.3.3    Forecast Trend (2022-2027)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2017-2021) 
        10.4.3    Forecast Trend (2022-2027)
    10.5    Others
11    Asia Pacific Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2017-2021) 
        11.1.3    Forecast Trend (2022-2027)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2017-2021) 
        11.2.3    Forecast Trend (2022-2027)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2017-2021) 
        11.3.3    Forecast Trend (2022-2027)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2017-2021) 
        11.4.3    Forecast Trend (2022-2027)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2017-2021) 
        11.5.3    Forecast Trend (2022-2027)
    11.6    Others
12    Latin America Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2017-2021) 
        12.1.3    Forecast Trend (2022-2027)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2017-2021) 
        12.2.3    Forecast Trend (2022-2027)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2017-2021) 
        12.3.3    Forecast Trend (2022-2027)
    12.4    Others
13    Middle East and Africa Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2017-2021) 
        13.1.3    Forecast Trend (2022-2027)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2017-2021) 
        13.2.3    Forecast Trend (2022-2027)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2017-2021) 
        13.3.3    Forecast Trend (2022-2027)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2017-2021) 
        13.4.3    Forecast Trend (2022-2027)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Genentech, Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Shionogi and Co., Ltd.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Seqirus Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    AstraZeneca PLC
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Novartis AG
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    GlaxoSmithKline Plc
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Others
16    Key Trends and Developments in the Market

 

List of Figures and Tables

1.    Global Influenza Medication Market: Key Industry Highlights, 2017 and 2027
2.    Global Influenza Medication Historical Market: Breakup by Type (USD Million), 2017-2021
3.    Global Influenza Medication Market Forecast: Breakup by Type (USD Million), 2022-2027
4.    Global Influenza Medication Historical Market: Breakup by Distribution Channels (USD Million), 2017-2021
5.    Global Influenza Medication Market Forecast: Breakup by Distribution Channels (USD Million), 2022-2027
6.    Global Influenza Medication Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Influenza Medication Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Influenza Medication Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Influenza Medication Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Influenza Medication Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Influenza Medication Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Influenza Medication Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Influenza Medication Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Influenza Medication Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Influenza Medication Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Influenza Medication Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Influenza Medication Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Influenza Medication Market Structure

Key Questions Answered in the Report

The global market size for Influenza medication reached a value of USD 1014.5 million by 2021.

The key factors driving the growth of the market for influenza medications are the increasing cases of influenza, risks of complications from the disease, its contagious nature, and low rates of vaccination. 

Major regions for the global market are North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

It spreads through skin-to-skin contact, exposure and contact to saliva, by touching a contaminated surface or by airborne respiratory droplets.

Amantadine and Rimantadine are common medications known to reduce the duration of influenza in humans.

Key players in the market are Genentech, Inc., Shionogi & Co., Ltd, Seqirus Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline Plc. and others.

Treatment of Influenza should begin within 48 hours for maximum clinical benefits. 

Influenza A is the most prevailing flu right now.

A respiratory sample test is the best way to find out whether a person has influenza or not.

Influenza can be fatal sometimes and to avoid chances of death, vaccines are important. 

It is advised to take the annual Influenza vaccine every six months. 

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER